Table 2.

Sex-Based Mean and Standard Deviation for VNT Titres Against SARS-CoV-2 Variants for Human Subjects Vaccinated with Different COVID-19 Vaccines.

Vaccine	Sex	Estimates	VIC31				Delta				Omicron
			1	2	3	4	1	2	3	4	1	2	3	4
AstraZeneca	Female	Mean	2.32	3.46	X	X	2.32	2.32	X	X	2.32	2.32	X	X
		SD	0.00	0.00	X	X	0.00	0.00	X	X	0.00	0.00	X	X
	Male	Mean	2.32	5.04	X	X	2.32	2.82	X	X	2.32	2.32	X	X
		SD	0.00	1.01	X	X	0.00	0.86	X	X	0.00	0.00	X	X
	All	Mean	2.32	4.25	X	X	2.32	2.57	X	X	2.32	2.32	X	X
		SD	0.00	1.08	X	X	0.00	0.61	X	X	0.00	0.00	X	X
Moderna	Female	Mean	2.32	7.16	X	X	2.32	5.99	X	X	2.32	2.57	X	X
		SD	0.00	1.11	X	X	0.00	0.76	X	X	0.00	0.61	X	X
	Male	Mean	2.32	6.93	X	X	2.32	5.05	X	X	2.32	2.82	X	X
		SD	0.00	1.17	X	X	0.00	1.28	X	X	0.00	0.80	X	X
	All	Mean	2.32	7.04	X	X	2.32	5.52	X	X	2.32	2.69	X	X
		SD	0.00	1.09	X	X	0.00	1.12	X	X	0.00	0.69	X	X
Pfizer	Female	Mean	2.32	7.22	3.75	8.93	2.32	6.36	3.37	7.39	2.32	2.73	2.32	5.95
		SD	0.00	1.08	0.66	1.07	0.00	1.04	0.79	0.82	0.00	0.67	0.00	1.22
	Male	Mean	2.32	6.76	4.61	9.32	2.32	5.76	4.34	8.82	2.32	2.49	2.32	6.07
		SD	0.00	0.92	0.71	0.64	0.00	1.06	0.97	1.09	0.00	0.38	0.00	1.43
	All	Mean	2.32	7.07	4.04	9.04	2.32	6.16	3.70	8.23	2.32	2.65	2.32	5.99
		SD	0.00	1.02	0.78	0.96	0.00	1.05	0.95	0.94	0.00	0.59	0.00	1.23

All VNT titres expressed as Log2 values. Values indicated as 2.32 represent titres below the assay detection limit. SD, Standard Deviation of Mean; 1 = pre-1^st dose; 2 = 2wk Post-2^nd dose; 3 = 6mo Post-2^nd dose and 4 = 2wk Post-3^rd dose. X = sample not available for analysis.